Citation Impact
1 from Science/Nature 76 standout
Citing Papers
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Works of Frédéric Fiteni being referenced
Health-related quality of life in elderly patients with advanced non-small cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy
2016
Endpoints in cancer clinical trials
2014
Author Peers
| Author | Oncology | PRM | Cancer Research | Surgery | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Frédéric Fiteni | 328 | 253 | 83 | 128 | 41 | 575 | |
| Joana B. Loureiro | 154 | 23 | 46 | 2 | 20 | 404 | |
| Patrick Turko | 97 | 17 | 15 | 9 | 26 | 259 | |
| Feng-Yim Chang | 1 | 12 | 345 | ||||
| P. J. Kruger | 1 | 20 | 333 | ||||
| Wade Ol | 3 | 53 | 76 | 12 | 353 |
All Works
Login with ORCID to disown or claim papers
Loading papers...